FFMMX
Price
$64.29
Change
+$0.34 (+0.53%)
Updated
Sep 11 closing price
Net Assets
117.47B
IAUTX
Price
$28.85
Change
+$0.18 (+0.63%)
Updated
Sep 11 closing price
Net Assets
3.8B
Interact to see
Advertisement

FFMMX vs IAUTX

FFMMX vs IAUTX Comparison Chart in %
View a ticker or compare two or three
VS
FFMMX vs. IAUTX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFMMX is a Buy and IAUTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFMMX has more cash in the bank: 117B vs. IAUTX (3.8B). FFMMX pays higher dividends than IAUTX: FFMMX (1.63) vs IAUTX (1.15). FFMMX was incepted earlier than IAUTX: FFMMX (6 years) vs IAUTX (24 years). IAUTX (0.93) is less costly to investors than FFMMX (0.36). IAUTX is a more actively managed with annual turnover of: 38.00 vs. FFMMX (30.00). FFMMX has a lower initial minimum investment than IAUTX: FFMMX (250) vs IAUTX (1000). FFMMX annual gain was more profitable for investors over the last year : 5.42 vs. IAUTX (2.35). FFMMX return over 5 years is better than : 39.64 vs. IAUTX (22.36).
FFMMXIAUTXFFMMX / IAUTX
Total Expense Ratio0.360.9339%
Annual Report Gross Expense Ratio0.360.9339%
Fund Existence6 years24 years-
Gain YTD8.9779.96990%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets117B3.8B3,082%
Annual Yield % from dividends1.631.15143%
Returns for 1 year5.422.35231%
Returns for 3 years37.8323.25163%
Returns for 5 years39.6422.36177%
Returns for 10 yearsN/A50.50-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLIO70.662.60
+3.82%
Helios Technologies
BALY9.170.10
+1.10%
Bally's Corporation
GIWWU10.61N/A
N/A
GigCapital8 Corp.
PAC203.46-1.10
-0.54%
Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares)
TENX1.86-0.09
-4.62%
Tenax Therapeutics